Chantal Michel1, Stephan Ruhrmann2, Benno G Schimmelmann3, Joachim Klosterkötter4, Frauke Schultze-Lutter3. 1. University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland; Shared first authorship chantal.michel@kjp.unibe.ch. 2. Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany Shared first authorship. 3. University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland; 4. Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
Abstract
OBJECTIVE: Impaired cognition is an important dimension in psychosis and its at-risk states. Research on the value of impaired cognition for psychosis prediction in at-risk samples, however, mainly relies on study-specific sample means of neurocognitive tests, which unlike widely available general test norms are difficult to translate into clinical practice. The aim of this study was to explore the combined predictive value of at-risk criteria and neurocognitive deficits according to test norms with a risk stratification approach. METHOD: Potential predictors of psychosis (neurocognitive deficits and at-risk criteria) over 24 months were investigated in 97 at-risk patients. RESULTS: The final prediction model included (1) at-risk criteria (attenuated psychotic symptoms plus subjective cognitive disturbances) and (2) a processing speed deficit (digit symbol test). The model was stratified into 4 risk classes with hazard rates between 0.0 (both predictors absent) and 1.29 (both predictors present). CONCLUSIONS: The combination of a processing speed deficit and at-risk criteria provides an optimized stratified risk assessment. Based on neurocognitive test norms, the validity of our proposed 3 risk classes could easily be examined in independent at-risk samples and, pending positive validation results, our approach could easily be applied in clinical practice in the future.
OBJECTIVE: Impaired cognition is an important dimension in psychosis and its at-risk states. Research on the value of impaired cognition for psychosis prediction in at-risk samples, however, mainly relies on study-specific sample means of neurocognitive tests, which unlike widely available general test norms are difficult to translate into clinical practice. The aim of this study was to explore the combined predictive value of at-risk criteria and neurocognitive deficits according to test norms with a risk stratification approach. METHOD: Potential predictors of psychosis (neurocognitive deficits and at-risk criteria) over 24 months were investigated in 97 at-risk patients. RESULTS: The final prediction model included (1) at-risk criteria (attenuated psychotic symptoms plus subjective cognitive disturbances) and (2) a processing speed deficit (digit symbol test). The model was stratified into 4 risk classes with hazard rates between 0.0 (both predictors absent) and 1.29 (both predictors present). CONCLUSIONS: The combination of a processing speed deficit and at-risk criteria provides an optimized stratified risk assessment. Based on neurocognitive test norms, the validity of our proposed 3 risk classes could easily be examined in independent at-risk samples and, pending positive validation results, our approach could easily be applied in clinical practice in the future.
Authors: Deanna M Barch; Juan Bustillo; Wolfgang Gaebel; Raquel Gur; Stephan Heckers; Dolores Malaspina; Michael J Owen; Susan Schultz; Rajiv Tandon; Ming Tsuang; Jim Van Os; William Carpenter Journal: Schizophr Res Date: 2013-05-22 Impact factor: 4.939
Authors: Ian Kelleher; Aileen Murtagh; Mary C Clarke; Jennifer Murphy; Caroline Rawdon; Mary Cannon Journal: Cogn Neuropsychiatry Date: 2012-09-20 Impact factor: 1.871
Authors: Jean Addington; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Jack A Addington; Tyrone D Cannon Journal: Schizophr Res Date: 2012-10-06 Impact factor: 4.939
Authors: Nikolaos Koutsouleris; Christian Gaser; Katja Patschurek-Kliche; Johanna Scheuerecker; Ronald Bottlender; Petra Decker; Gisela Schmitt; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl Journal: Hum Brain Mapp Date: 2011-08-30 Impact factor: 5.038
Authors: Amber De Herdt; Martien Wampers; Davy Vancampfort; Marc De Hert; Luc Vanhees; Hella Demunter; Ludwina Van Bouwel; Emanuel Brunner; Michel Probst Journal: Schizophr Res Date: 2013-07-05 Impact factor: 4.939
Authors: Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung Journal: JAMA Psychiatry Date: 2013-01 Impact factor: 21.596
Authors: Manuel J Cuesta; Elena García de Jalón; Maria S Campos; Berta Ibáñez; Ana M Sánchez-Torres; Víctor Peralta Journal: Schizophr Res Date: 2012-09-16 Impact factor: 4.939
Authors: Paolo Fusar-Poli; Andreas Bechdolf; Matthew John Taylor; Ilaria Bonoldi; William T Carpenter; Alison Ruth Yung; Philip McGuire Journal: Schizophr Bull Date: 2012-05-15 Impact factor: 9.306
Authors: Francesco Carletti; James B Woolley; Sagnik Bhattacharyya; Rocio Perez-Iglesias; Paolo Fusar Poli; Lucia Valmaggia; Matthew R Broome; Elvira Bramon; Louise Johns; Vincent Giampietro; Steve C R Williams; Gareth J Barker; Philip K McGuire Journal: Schizophr Bull Date: 2012-04-03 Impact factor: 9.306
Authors: Maria Niarchou; Stanley Zammit; James Walters; Glyn Lewis; Michael John Owen; Marianne Bernadette van den Bree Journal: Am J Psychiatry Date: 2013-05 Impact factor: 18.112
Authors: Barbara A Cornblatt; Ricardo E Carrión; Andrea Auther; Danielle McLaughlin; Ruth H Olsen; Majnu John; Christoph U Correll Journal: Am J Psychiatry Date: 2015-06-05 Impact factor: 18.112
Authors: Nikolaos Koutsouleris; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Marlene Rosen; Anne Ruef; Dominic B Dwyer; Marco Paolini; Katharine Chisholm; Joseph Kambeitz; Theresa Haidl; André Schmidt; John Gillam; Frauke Schultze-Lutter; Peter Falkai; Maximilian Reiser; Anita Riecher-Rössler; Rachel Upthegrove; Jarmo Hietala; Raimo K R Salokangas; Christos Pantelis; Eva Meisenzahl; Stephen J Wood; Dirk Beque; Paolo Brambilla; Stefan Borgwardt Journal: JAMA Psychiatry Date: 2018-11-01 Impact factor: 21.596
Authors: Jean Addington; Lu Liu; Diana O Perkins; Ricardo E Carrion; Richard S E Keefe; Scott W Woods Journal: Schizophr Bull Date: 2016-10-25 Impact factor: 9.306
Authors: Martina Uttinger; Erich Studerus; Sarah Ittig; Ulrike Heitz; Frauke Schultze-Lutter; Anita Riecher-Rössler Journal: Int J Methods Psychiatr Res Date: 2017-12-21 Impact factor: 4.035
Authors: Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman Journal: Schizophr Res Date: 2018-08-02 Impact factor: 4.939
Authors: Ricardo E Carrión; Barbara A Cornblatt; Cynthia Z Burton; Ivy F Tso; Andrea M Auther; Steven Adelsheim; Roderick Calkins; Cameron S Carter; Tara Niendam; Tamara G Sale; Stephan F Taylor; William R McFarlane Journal: Am J Psychiatry Date: 2016-07-01 Impact factor: 18.112
Authors: Nikolaos Koutsouleris; Anita Riecher-Rössler; Eva M Meisenzahl; Renata Smieskova; Erich Studerus; Lana Kambeitz-Ilankovic; Sebastian von Saldern; Carlos Cabral; Maximilian Reiser; Peter Falkai; Stefan Borgwardt Journal: Schizophr Bull Date: 2014-06-09 Impact factor: 9.306